C07K

Watch

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Subclasses

Not Available
Subclass Title
1/00 General processes for the preparation of peptides
1/02 General processes for the preparation of peptides in solution
1/04 General processes for the preparation of peptides on carriers
1/06 General processes for the preparation of peptides using protecting groups or activating agents
1/08 General processes for the preparation of peptides using protecting groups or activating agents using activating agents

more results

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
9820938 Stable liquid formulation of AMG 416 (etelcalcetide) Jun 27, 14 Nov 21, 17 , Amgen Inc.
9821010 Methods for expansion or depletion of T-regulatory cells Feb 06, 14 Nov 21, 17 , The General Hospital Corporation
9821012 Chimeric antigen receptor and methods of use thereof Jan 30, 17 Nov 21, 17 , The Regents of the University of California
9821016 Genetically modified paramyxovirus for treatment of tumor diseases Oct 22, 12 Nov 21, 17 , Eberhard-Karls-Universitaet Tuebingen Universitaetsklinikum
9821023 Methods for the treatment of central nervous system (CNS) disorders and mood disorders Nov 17, 15 Nov 21, 17 , The Arizona Board of Regents on behalf of The University of Arizona
9821028 Methods of controlling parasitic worms in animals Jul 11, 14 Nov 21, 17 , - Wisconsin Alumni Research Foundation
9821029 in poultry Jul 16, 15 Nov 21, 17 , - Wisconsin Alumni Research Foundation; The United States of America as represented by the Secretary of Agriculture;
9821035 Preparation for preventing or treating type I diabetes Aug 22, 13 Nov 21, 17 , REGIMMUNE CORPORATION
9821036 Therapeutic agents comprising a GLP-2 peptide and elastin-like peptides Aug 10, 15 Nov 21, 17 , Duke University
9821037 Compounds and method of use as anti-infection compounds and therapeutic agents to regulate cholesterol metabolism Apr 21, 14 Nov 21, 17 , University of Kentucky Research Foundation
9821038 Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity Feb 13, 17 Nov 21, 17 , Amicus Therapeutics, Inc.
9821039 Albumin fusion proteins Oct 29, 07 Nov 21, 17 , Albumedix A/S
9821043 Anti-HER2 vaccine based upon AAV derived multimeric structures Sep 14, 12 Nov 21, 17 , Medigene AG
9821046 Composition and uses thereof Jan 21, 14 Nov 21, 17 , Oxford University Innovation Limited
9821047 Enhancing immunity to tuberculosis Aug 29, 14 Nov 21, 17 , Longhorn Vaccines and Diagnostics. LLC
9821048 infections Jun 24, 15 Nov 21, 17 , IMEVAX GMBH
9821050 Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions Mar 15, 13 Nov 21, 17 , The University of North Carolina at Chapel Hill; Vanderbilt University;
9821052 Reverse genetics systems Jul 30, 10 Nov 21, 17 , Seqirus UK Limited
9821053 Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins Apr 17, 15 Nov 21, 17 , Duke University; Los Alamos National Security, LLC; The UAB Research Foundation; Beth Israel Deaconess Medical Center;
9821057 Anti-IL-6 antibody for use in the treatment of cachexia Mar 30, 15 Nov 21, 17 , AlderBio Holdings LLC

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2017/0327,532 METHODS, COMPOSITIONS, AND KITS USING HETEROGENEOUS CATALYSTS Jul 31, 17 Nov 16, 17 , Not available
2017/0327,533 METHOD FOR SPECIFIC CLEAVAGE OF C Alpha-C BOND AND SIDE CHAIN OF PROTEIN AND PEPTIDE, AND METHOD FOR DETERMINING AMINO ACID SEQUENCE May 12, 17 Nov 16, 17 , Not available
2017/0327,534 SEPARATION MATRIX Sep 30, 16 Nov 16, 17 , Not available
2017/0327,535 AFFINITY SEPARATION MATRIX FOR PURIFYING PROTEIN CONTAINING IMMUNOGLOBULIN K CHAIN VARIABLE REGION Jul 26, 17 Nov 16, 17 , Kaneka Corporation
2017/0327,536 NEUROTOXIC TARGET FOR AMYLOSPHEROID, METHOD AND MATERIAL FOR REDUCING THE NEUROTOXICITY OF AMYLOSPHEROID, AND USE THEREOF Jul 27, 17 Nov 16, 17 , TAO Health Life Pharma Co., Ltd.
2017/0327,537 BINDING LIGAND LINKED DRUG DELIVERY CONJUGATES OF TUBULYSINS Jan 30, 17 Nov 16, 17 , Not available
2017/0327,538 Peptide Inhibitors of Sodium Channels May 10, 17 Nov 16, 17 , Not available
2017/0327,539 Peptide and Complex of Same, Scaffold for Tissue Repair and Surface Treatment Method for Same, and Surface Treatment Solution or Set of Treatment Solutions Jul 28, 17 Nov 16, 17 , Not available
2017/0327,540 METHOD FOR ACYLATING A CYCLIC PEPTIDE Dec 04, 15 Nov 16, 17 , Not available
2017/0327,541 METHODS FOR SYNTHESIZING alpha4ß7 PEPTIDE ANTAGONISTS Mar 23, 17 Nov 16, 17 , Not available
2017/0327,542 TEICOPLANIN ANALOGS AND USES THEREOF Jan 26, 15 Nov 16, 17 , Academia Sinica
2017/0327,543 POLYIONIC PAPILLOMA VIRUS-LIKE PARTICLE (VLP) VACCINES Jan 31, 17 Nov 16, 17 , Not available
2017/0327,544 RECOMBINANT VIRAL VECTORS Jul 31, 17 Nov 16, 17 , Not available
2017/0327,545 Modified Kappa Light Chain-Binding Polypeptides Dec 11, 15 Nov 16, 17 , Not available
2017/0327,546 Novel Insecticidal Proteins and Methods for Their Use May 23, 17 Nov 16, 17 , PIONEER HI-BRED INTERNATIONAL, INC.
2017/0327,547 Novel Chimeric Insecticidal Proteins Toxic or Inhibitory to Lepidopteran Pests Jul 21, 17 Nov 16, 17 , Monsanto Technology LLC
2017/0327,548 Charged Nutritive Fragments, Proteins and Methods Apr 19, 17 Nov 16, 17 , Not available
2017/0327,549 Adenylation Enzyme Inhibitors Aug 26, 15 Nov 16, 17 , Stichting het Nederlands Kanker Instituut - Antoni van Leeuwenhoek ziekenhuis
2017/0327,550 NBP158 AND USES THEREOF Dec 09, 14 Nov 16, 17 , Not available
2017/0327,551 METHODS OF USING COMPOSITIONS COMPRISING FUSION VARIANTS OF FGF19 POLYPEPTIDES FOR REDUCING GLUCOSE LEVELS IN A SUBJECT Aug 01, 17 Nov 16, 17 , Not available

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

UPGRADE MEMBERSHIP CANCEL
We are sorry but Dashboard Viewer is not able to watch the Technologies/Sub-Technologies.